Join host Andy Tanner and guests Noah Davidson and Corey Halliday as they discuss the current trends and investment opportunities in the food and pharmaceutical sectors.
They dive into the impacts of new appetite-suppressant drugs like Ozempic, strategies to manage risk in volatile pharmaceutical stocks, and the resilience of staple food companies.
The team also explores various investment strategies, including the use of options and ETFs to balance potential gains with risk.
Tune in for valuable insights on navigating the evolving market landscape.